YIH
Y-Intercept (HK) Portfolio holdings
AUM
$4.09B
This Quarter Return
+8.69%
1 Year Return
+5.6%
3 Year Return
+25.71%
5 Year Return
–
10 Year Return
–
AUM
$393M
AUM Growth
+$393M
(+5.4%)
Cap. Flow
+$16M
Cap. Flow
% of AUM
4.08%
Top 10 Holdings %
Top 10 Hldgs %
14.62%
Holding
983
New
387
Increased
110
Reduced
90
Closed
395
Top Buys
| 1 |
Linde
LIN
|
$12.2M |
| 2 |
Moderna
MRNA
|
$7.82M |
| 3 |
Qualcomm
QCOM
|
$4.48M |
| 4 |
Advanced Micro Devices
AMD
|
$4.24M |
| 5 |
Biogen
BIIB
|
$3.87M |
Top Sells
| 1 |
Baidu
BIDU
|
$3.44M |
| 2 |
Kimberly-Clark
KMB
|
$2.7M |
| 3 |
Moody's
MCO
|
$2.68M |
| 4 |
United Parcel Service
UPS
|
$2.64M |
| 5 |
McDonald's
MCD
|
$2.55M |
Sector Composition
| 1 | Healthcare | 17.91% |
| 2 | Technology | 17.83% |
| 3 | Consumer Discretionary | 11.15% |
| 4 | Industrials | 9.32% |
| 5 | Materials | 8.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Linde
LIN
$224B
| $12.2M | 3.11% | +42,339 | New | +$12.2M |
|
|
2
Moderna
MRNA
$9.37B
| $8.97M | 2.28% | 38,178 +33,295 | +682% | +$7.82M |
|
3
Apple
AAPL
$3.45T
| $8M | 2.03% | 58,415 -4,173 | -7% | -$572K |
|
|
4
Biogen
BIIB
$19.4B
| $4.79M | 1.22% | 13,831 +11,168 | +419% | +$3.87M |
|
|
5
Qualcomm
QCOM
$173B
| $4.48M | 1.14% | +31,371 | New | +$4.48M |
|
6
UnitedHealth
UNH
$281B
| $4.44M | 1.13% | 11,088 +6,531 | +143% | +$2.62M |
|
|
7
Advanced Micro Devices
AMD
$264B
| $4.24M | 1.08% | +45,173 | New | +$4.24M |
|
8
Alphabet (Google) Class C
GOOG
$2.58T
| $4.22M | 1.07% | 1,684 +627 | +59% | +$1.57M |
|
9
TAL Education Group
TAL
$6.46B
| $3.12M | 0.79% | 123,454 +85,557 | +226% | +$2.16M |
|
10
Northrop Grumman
NOC
$84.5B
| $3.01M | 0.77% | 8,288 +262 | +3% | +$95.2K |
|
11
Oracle
ORCL
$635B
| $2.6M | 0.66% | +33,444 | New | +$2.6M |
|
12
Berkshire Hathaway Class B
BRK.B
$1.09T
| $2.53M | 0.64% | 9,114 -261 | -3% | -$72.5K |
|
13
KLA
KLAC
$115B
| $2.47M | 0.63% | +7,620 | New | +$2.47M |
|
14
New Oriental
EDU
$7.85B
| $2.37M | 0.6% | 289,636 +208,530 | +257% | +$1.71M |
|
15
Archer Daniels Midland
ADM
$30.1B
| $2.37M | 0.6% | +39,116 | New | +$2.37M |
|
16
Regeneron Pharmaceuticals
REGN
$61.5B
| $2.35M | 0.6% | +4,206 | New | +$2.35M |
|
17
Newmont
NEM
$81.7B
| $2.15M | 0.55% | 33,922 +29,219 | +621% | +$1.85M |
|
18
Snap
SNAP
$12.1B
| $2.13M | 0.54% | 31,259 +25,052 | +404% | +$1.71M |
|
19
Novartis
NVS
$245B
| $2.12M | 0.54% | +23,276 | New | +$2.12M |
|
20
Charter Communications
CHTR
$36.3B
| $2.12M | 0.54% | 2,933 +1,800 | +159% | +$1.3M |
|
21
Salesforce
CRM
$245B
| $2.09M | 0.53% | +8,549 | New | +$2.09M |
|
22
Nucor
NUE
$34.1B
| $2.05M | 0.52% | +21,329 | New | +$2.05M |
|
23
Baker Hughes
BKR
$44.8B
| $1.92M | 0.49% | +83,750 | New | +$1.92M |
|
24
Vipshop
VIPS
$8.25B
| $1.85M | 0.47% | 92,328 +75,444 | +447% | +$1.51M |
|
25
BioMarin Pharmaceuticals
BMRN
$11.2B
| $1.79M | 0.46% | +21,479 | New | +$1.79M |
|